R/R NHL

Clinical trials for R/R NHL explained in plain language.

Never miss a new study

Get alerted when new R/R NHL trials appear

Sign up with your email to follow new studies for R/R NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New CAR-T therapy targets two proteins to fight tough leukemia and lymphoma

Disease control Not yet recruiting

This early-phase trial tests a new type of CAR-T cell therapy that targets two proteins (CD19 and CD22) on cancer cells. It is for people with relapsed or refractory B-cell acute lymphoblastic leukemia or non-Hodgkin lymphoma. Participants receive a single infusion of these modif…

Matched conditions: R/R NHL

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

R/R NHL

Get alerted when new R/R NHL trials appear

New CAR-T therapy targets two proteins to fight tough leukemia and lymphoma